migraine

Views & Analysis

Value-based healthcare: What’s it worth to you?

It takes healthy people to make a healthy society – and that must be taken into account when we are talking about value-based healthcare.

News

Concerns over Teva migraine drug because of manufacturing is...

There are concerns that launch of Teva’s migraine drug may be delayed because of issues uncovered by the FDA at a manufacturing plant run by South Korea’s Celltrion.

News

Breakthrough migraine prevention treatment approved in Europ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine prevention jab available for adult patients in Euro

News

A sad young woman is sitting in her kitchen with a headache

Lilly joins CGRP race to cure migraine

Eli Lilly are gearing up to announce details from the latest Emgality analysis, which can potentially push the biotech to the leading pack of the migraine cure race, among Allergan, Amgen a

News